CareCloud, Inc. (NASDAQ: CCLD) reported fourth‑quarter 2025 financial results on March 12, 2026. Revenue rose to $34.42 million, up 21.6% year‑over‑year from $28.24 million in Q4 2024. GAAP earnings per share were $0.07, below the consensus estimate of $0.11, but the company posted a GAAP net income of $0.04 per share, marking its seventh consecutive quarter of positive earnings. Adjusted EBITDA increased 15% to $7.7 million, driven by a 20.9% rise in the technology‑enabled segment and a 70% call‑automation rate from its AI Center of Excellence.
Full‑year 2025 revenue totaled $120.5 million, an 8.7% increase from $110.8 million in 2024. The company posted a GAAP EPS of $0.10, its first full‑year positive EPS since its 2014 IPO. Adjusted EBITDA for the year was $27.5 million, up 14.5% YoY. Management raised its 2026 revenue guidance to $128 million–$132 million and its GAAP EPS guidance to $0.20–$0.23, a 100%–130% increase over the 2025 full‑year EPS.
CareCloud confirmed that the Medsphere acquisition closed on August 22 2025. Integration costs are expected to normalize over the next two quarters, and the company has already begun leveraging Medsphere’s inpatient platform to expand its care‑continuum offering. The company also noted that its AI Center of Excellence continues to advance tools that automate revenue‑cycle workflows and support clinicians in real time.
Stephen Snyder, CEO, said, "2025 was the year CareCloud proved its model. We exceeded revenue guidance, introduced an inpatient product suite through our acquisitions of Medsphere and Map App, launched AI products that are already changing how care is delivered, and posted our first full‑year positive EPS since going public." A. Hadi Chaudhry, Co‑CEO, added, "The numbers tell a clear story: $28.6 million in operating cash flow, a fully repaid credit line, thirteen consecutive monthly preferred dividend payments, and GAAP net income up 37.5% year‑over‑year— all while funding four acquisitions."
Investors welcomed the results, citing the strong revenue beat and optimistic guidance. The company’s revenue growth, driven by the Medsphere acquisition and AI product launches, and its first full‑year positive EPS since IPO, reinforced confidence in its growth trajectory.
The results underscore CareCloud’s ability to scale its technology‑enabled platform while managing integration costs. The 70% call‑automation rate demonstrates the effectiveness of its AI initiatives, and the raised 2026 outlook signals management’s confidence that the company can sustain momentum in a competitive healthcare‑technology market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.